Select Page

Home / Share Price Target / Windlas

Windlas Biotech Share Price Target 2024, 2025, 2026 to 2039 With Charts

Windlas Biotech Limited

Company LogoSymbol: WINDLAS
Price: ₹906.34
Exchange: NSE
Healthcare -> Drug Manufacturers - Specialty & Generic
Show Table of Contents

Windlas Biotech Brief Company Overview

Windlas Biotech Limited:

Leading CDMO Provider with a Comprehensive Product Range

Founded in 2001, Windlas Biotech Limited is a renowned contract development and manufacturing organization (CDMO) based in Gurugram, India.

The company offers a comprehensive suite of CDMO services, from product discovery to commercial manufacturing of generic products.

Its diverse product portfolio includes tablets, capsules, pouches, sachets, liquid bottles, and a wide range of generic products, including fixed dosage combinations, modified release combinations, customized generics, and chewable or dispersible formulations.

Windlas Biotech has established a strong reputation in the industry for its commitment to quality and innovation.


Advertisement

Windlas Biotech Financial Performance

MetricValueDescription
Market Capital1,150.37 CroreMarket valuation of Windlas Biotech's shares.
Revenue (TTM)600.38 CroreTotal revenue generated by Windlas Biotech over the past twelve months.
Net Income (TTM)+52.63 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin10.44%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin8.76%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+35.5%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+64.3%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
1.51Company's total debt divided by total shareholder equity.
Total Debt6.3 CroreSum of Windlas Biotech's current & long-term financial obligations.
Total Cash168.64 CroreTotal amount of liquid funds available to Windlas Biotech.
Beta0.49Beta is less than 1 indicating that the Windlas Biotech's price is less volatile than the market.

Is Windlas Biotech A Good Buy For Long Term?

Windlas Biotech, a small-cap stock with a market cap of INR 1,285.76 Crore, exhibits promising financial performance. Over the last 12 months (TTM), it generated revenue of INR 600.38 Crore and net profit of INR 52.63 Crore. With an impressive profit margin of 8.76%, it has witnessed a 64.3% increase in earnings and 35.5% growth in revenue compared to the same quarter last year. While the company has a debt of INR 6.3 Crore, it maintains a healthy cash balance of INR 168.64 Crore. Given its strong financial position, consistent growth, and attractive returns in recent years, Windlas Biotech appears to be a promising investment for the long term.

To predict the Windlas Biotech's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Windlas Biotech Share Price Target For 2024

Windlas Biotech Targets For 2024 Chart

The line chart displays the monthly closing prices of Windlas Biotech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Windlas Biotech shares in 2024, see the table below.

Advertisement

Windlas Biotech Share Price Target Table For 2024

Windlas Biotech's LevelsValueReason/Importance
2024 Target 31001.27 (+10.47%)Custom Fibonacci Extension Lvl 50%
2024 Target 2973.80 (+7.44%)Fibonacci Extension Level 123.6%
2024 Target 1951.14 (+4.94%)Custom Fibonacci Extension Lvl 23.6%
Current Price906.34Windlas Biotech's 1 share price as of Thu 05 Sep 2024
Stop Loss 1892.58 (-1.52%)Price Action: Chart
Stop Loss 2883.65 (-2.51%)Price Action: Chart
Stop Loss 3858.00 (-5.34%)Price Action: 28 Aug 2024 High

Summary: Windlas Biotech Share Price Prediction For 2024

In summary, Windlas Biotech has surged by ₹477.59, achieving a notable +111.39% increase from 1st January 2024 to 05 Sep 2024. Our analysis of Windlas Biotech for 2024 predicts an additional rise of 4.94% to 10.47% by the end of 2024 with three potential targets T1: 951.14, T2: 973.80, T3: 1001.27. Stop Loss at SL1: 892.58, SL2: 883.65, SL3: 858.00.

Windlas Biotech has a 52-week high of ₹929.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹311.60, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Windlas Biotech.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Windlas Biotech Share Price Target For 2025

Windlas Biotech Targets For 2025 Chart

The line chart displays the monthly closing prices of Windlas Biotech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Windlas Biotech shares in 2025, see the table below.

Advertisement

Windlas Biotech Share Price Target Table For 2025

Windlas Biotech's LevelsValueReason/Importance
2025 Target 31355.90 (+49.6%)Price Action: Chart
2025 Target 21330.62 (+46.81%)Price Action: Chart
2025 Target 11317.45 (+45.35%)Custom Fibonacci Extension Lvl 64.9%
Current Price906.34Windlas Biotech's 1 share price as of Thu 05 Sep 2024
Stop Loss 1811.54 (-10.46%)Price Action: 03 Sep 2024 Low
Stop Loss 2797.00 (-12.07%)Price Action: 07 Aug 2024 Low
Stop Loss 3786.54 (-13.22%)Price Action: 20 Aug 2024 Low

Summary: Windlas Biotech Share Price Prediction For 2025

In summary, Windlas Biotech has surged by ₹477.59, achieving a notable +111.39% increase from 1st January 2024 to 05 Sep 2024. Our analysis of Windlas Biotech for 2025 predicts an additional rise of 45.35% to 49.6% by the end of 2025 with three potential targets T1: 1317.45, T2: 1330.62, T3: 1355.90. Stop Loss at SL1: 811.54, SL2: 797.00, SL3: 786.54.

Windlas Biotech has a All-Time high of ₹929.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹311.60, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Windlas Biotech, we have created a specific page for that check here: Windlas Biotech Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Windlas Biotech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

Windlas Biotech Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Windlas Biotech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 17.47% over the next 15 years.

For complete year by year Windlas Biotech long term share price target from 2024, 2025 to 2039 check the below table.

Windlas Biotech Share Price Target Table From 2024, 2025, 2026 to 2039

YearWindlas Biotech TargetYoY Change %
2024₹906.34[Current Price]
2024₹976.697.76%
2025₹1,552.8258.98%
2026₹2,077.9133.81%
2027₹2,584.9824.4%
2028₹3,204.7123.97%
2029₹3,758.8817.29%
2030₹4,370.7516.27%
2031₹4,844.5810.84%
2032₹5,303.029.46%
2033₹5,988.8712.93%
2034₹6,541.079.22%
2035₹7,188.679.9%
2036₹7,611.255.87%
2037₹8,021.055.38%
2038₹8,773.039.37%
2039₹9,302.126.03%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Windlas Biotech Past Performance

WINDLAS main
Windlas Biotech has been listed on NSE for more than 3 years.
  • In 2021, Windlas Biotech opening price was ₹392
  • As of Thu 05 Sep 2024 the price stands at ₹906.34.
  • This represents a Compound Annual Growth Rate (CAGR) of 23.31%.
  • In 3 years, an investment of 10,000 would have become ₹23,120.91.

As we wrap up, we hope you like our study on Windlas Biotech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Windlas Biotech Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter